ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

UPCI Opens New Facility; Gomella Wins NCI Award.

July 4, 2003

In Brief: Senate approves $13.69 Billion for NIH, House To Act This Week; Amounts Are Close

September 19, 1997

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983

House Still Sees Problems In NIH Financial Management

July 5, 1991